Publicacións nas que colabora con Jerónimo Pachón Díaz (25)

2022

  1. Development of an Anti-Acinetobacter baumannii Biofilm Phage Cocktail: Genomic Adaptation to the Host

    Antimicrobial Agents and Chemotherapy, Vol. 66, Núm. 3

2021

  1. Identification and validation of clinical phenotypes with prognostic implications in patients admitted to hospital with COVID-19: a multicentre cohort study

    The Lancet Infectious Diseases, Vol. 21, Núm. 6, pp. 783-792

2019

  1. Combined use of the Ab105-2ϕ∆CI lytic mutant phage and different antibiotics in clinical isolates of multi-resistant Acinetobacter baumannii

    Microorganisms, Vol. 7, Núm. 11

2018

  1. Relationship between the Quorum network (sensing/quenching) and clinical features of pneumonia and bacteraemia caused by A. Baumannii

    Frontiers in Microbiology, Vol. 9

2017

  1. Overproduction of Outer membrane protein a by Acinetobacter baumannii as a risk factor for nosocomial pneumonia, bacteremia, and mortality rate increase

    Journal of Infectious Diseases, Vol. 215, Núm. 6, pp. 966-974

  2. Quorum sensing network in clinical strains of A. baumannii: AidA is a new quorum quenching enzyme

    PLoS ONE, Vol. 12, Núm. 3

  3. Response to bile salts in clinical strains of Acinetobacter baumannii lacking the adeABC efflux pump: Virulence associated with quorum sensing

    Frontiers in Cellular and Infection Microbiology, Vol. 7, Núm. MAY

2016

  1. Acinetobacter baumannii in critically ill patients: Molecular epidemiology, clinical features and predictors of mortality

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 34, Núm. 9, pp. 551-558

  2. Genomic evolution of two Acinetobacter baumannii clinical strains from ST-2 clones isolated in 2000 and 2010 (ST-2_clon_2000 and ST-2_clon_2010)

    Genome Announcements, Vol. 4, Núm. 5

2015

  1. Reduced susceptibility to biocides in Acinetobacter baumannii: Association with resistance to antimicrobials, epidemiological behaviour, biological cost and effect on the expression of genes encoding porins and efflux pumps

    Journal of Antimicrobial Chemotherapy, Vol. 70, Núm. 12, pp. 3222-3229

2014

  1. Characterization of plasmids carrying the blaOXA-24/40 carbapenemase gene and the genes encoding the AbkA/AbkB proteins of a toxin/antitoxin system

    Journal of Antimicrobial Chemotherapy, Vol. 69, Núm. 10, pp. 2629-2633

  2. Monotherapy versus combination therapy for sepsis due to multidrug-resistant Acinetobacter baumannii: Analysis of a multicentre prospective cohort

    Journal of Antimicrobial Chemotherapy, Vol. 69, Núm. 11, pp. 3119-3126

2013

  1. Actividad de 18 agentes antimicrobianos frente a aislados clínicos de Acinetobacter baumannii: segundo estudio nacional multicéntrico (proyecto GEIH-REIPI-Ab 2010)

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 31, Núm. 1, pp. 4-9

  2. Contribution of efflux pumps, porins, and β-lactamases to multidrug resistance in clinical isolates of Acinetobacter baumannii

    Antimicrobial Agents and Chemotherapy, Vol. 57, Núm. 11, pp. 5247-5257

  3. Erratum: Actividad de 18 agentes antimicrobianos frente a aislados clínicos de Acinetobacter baumannii: Segundo estudio nacional multicéntrico (proyecto GEIH-REIPI-Ab 2010) (Enfermedades Infecciosas y Microbiologia Clinica (2013) 31 (4-9))

    Enfermedades Infecciosas y Microbiologia Clinica

2011

  1. Outer membrane vesicles as an acellular vaccine against Acinetobacter baumannii

    Vaccine, Vol. 29, Núm. 34, pp. 5705-5710

2010

  1. Clinical features of infections and colonization by Acinetobacter genospecies 3

    Journal of Clinical Microbiology, Vol. 48, Núm. 12, pp. 4623-4626

2009

  1. Genetic variability among ampC genes from Acinetobacter genomic species 3

    Antimicrobial Agents and Chemotherapy, Vol. 53, Núm. 3, pp. 1177-1184

  2. In vitro activity and in vivo efficacy of clavulanic acid against Acinetobacter baumannii

    Antimicrobial Agents and Chemotherapy, Vol. 53, Núm. 10, pp. 4298-4304

2008

  1. False extended-spectrum β-lactamase detection in Acinetobacter spp. due to intrinsic susceptibility to clavulanic acid

    Journal of Antimicrobial Chemotherapy, Vol. 61, Núm. 2, pp. 301-308